Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?

por Qayyum, Tahir, McArdle, Peter, Orange, Clare, Seywright, Morag, Horgan, Paul, Oades, Grenville, Aitchison, Michael, Edwards, Joanne
Publicado 2013

SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

por Gao, Meiling, Patel, Rachana, Ahmad, Imran, Fleming, Janis, Edwards, Joanne, McCracken, Stuart, Sahadevan, Kanagasabai, Seywright, Morag, Norman, Jim, Sansom, Owen, Leung, Hing Y
Publicado 2012